Recent 8-K filings for CRVW
Highest-materiality recent filing
CareView converts $26.2M of Replacement Notes into 262M shares at $0.10/share
- Majority and minority investors converted $26.2M Replacement Notes into 262M shares at $0.10/share; lockup ends Dec 31, 2023.
- HealthCor Parties initially convert only 50% of their Notes; remaining 50% awaits stockholder approval to increase authorized shares from 500M to 800M.
-
CareView extends credit agreement maturity to March 31, 2026 under Thirteenth Amendment
Maturity date extended to March 31, 2026 via Thirteenth Amendment to Credit Agreement with PDL Investment Holdings.
-
CareView extends credit maturity to September 30, 2025 via Eleventh Amendment
Eleventh Amendment to Credit Agreement extends Maturity Date to September 30, 2025.
-
CareView adopts 2024 Stock Incentive Plan, grants 29.8M options at $0.06; COO receives 8.9M options
Board approved 2024 Stock Incentive Plan authorizing 30,000,000 shares for awards effective March 5, 2024.
-
CareView amends credit agreement: PIK interest, mandatory prepayments, maturity extended to Dec 2024
Accrued interest on Tranche One and Three loans to be paid-in-kind (added to principal) instead of cash.
-
CareView noteholders convert $18M notes to 180M shares at $0.10 per share
Noteholders converted $18,000,000 Replacement Notes into 180,000,000 common shares on May 24, 2023 at $0.10/share.
-
CareView Communications enters 30th amendment to credit modification agreement
Thirtieth Amendment entered on April 29, 2023; specific terms not detailed in filing text.
-
CareView enters 29th amendment to credit agreement, extending forbearance again
Twenty-Ninth Amendment to Modification Agreement entered on March 31, 2023.
-
CareView converts $26.2M of debt into 262M shares at $0.10 per share
Converted $26.2M aggregate principal of Replacement Notes into 262M shares of common stock at $0.10/share.
-
CareView converts $26.2M of Replacement Notes into 262M shares at $0.10/share
Majority and minority investors converted $26.2M Replacement Notes into 262M shares at $0.10/share; lockup ends Dec 31, 2023.
-
Filing reports entry into Twenty-Sixth Amendment to Modification Agreement with lender PDL Investment Holdings.
-
CareView exchanges $88.3M debt and warrants for $44.9M replacement notes
Aggregate $88.3M notes and ~15.4M share warrants cancelled; replaced with $44.9M senior secured convertible notes.
-
CareView Communications dismisses BDO, appoints RRBB as new auditor effective Aug 24, 2022
Dismissed BDO USA LLP and appointed Rosenberg Rich Baker Berman as principal independent auditor, effective Aug 24, 2022.
-
CareView Communications dismisses BDO USA, engages RRBB as new auditor
BDO USA dismissed as auditor; its 2021/2020 reports contained a going concern paragraph.
-
On July 12, 2022, CareView entered into allonges suspending interest accrual on 2014-2020 convertible notes.
Materiality & sentiment trend
Max materiality 0.90 · Median 0.60 · Most common event debt